Ascend Wellness Holdings (AAWH) Net Cash Flow Growth (1y) (2021 - 2026)
Ascend Wellness Holdings (AAWH) Net Cash Flow Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 112.26% |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | -44.11% |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | -236.85% |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | -1,047.81% |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | -1,020.00% |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | -807.00% |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 444.33% |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | -107.45% |
| 10 | Ascend Wellness Holdings | - | - | 44.88 Mn | -310.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -310.15% |
| Dec 31, 2025 | -106.95% |
| Sep 30, 2025 | 56.61% |
| Jun 30, 2025 | -144.07% |
| Mar 31, 2025 | 2,874.75% |
| Dec 31, 2024 | 167.56% |
| Sep 30, 2024 | -346.88% |
| Jun 30, 2024 | 305.89% |
| Mar 31, 2024 | 146.59% |
| Dec 31, 2023 | 149.79% |
| Sep 30, 2023 | 91.61% |
| Jun 30, 2023 | -61.74% |
| Mar 31, 2023 | 92.73% |
| Dec 31, 2022 | 64.82% |
| Sep 30, 2022 | -149.01% |
| Jun 30, 2022 | -107.93% |
| Mar 31, 2022 | -325.47% |
| Dec 31, 2021 | -249.72% |
| Sep 30, 2021 | 18,436.01% |
| Jun 30, 2021 | 210.50% |